DE69426669D1 - Tierarzneimittel, das einen protonenpumpeninhibitor enthält - Google Patents

Tierarzneimittel, das einen protonenpumpeninhibitor enthält

Info

Publication number
DE69426669D1
DE69426669D1 DE69426669T DE69426669T DE69426669D1 DE 69426669 D1 DE69426669 D1 DE 69426669D1 DE 69426669 T DE69426669 T DE 69426669T DE 69426669 T DE69426669 T DE 69426669T DE 69426669 D1 DE69426669 D1 DE 69426669D1
Authority
DE
Germany
Prior art keywords
proton pump
pump inhibitor
product containing
medicinal product
veterinary medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69426669T
Other languages
English (en)
Other versions
DE69426669T2 (de
Inventor
Stig-Goeran Arthur Olovson
Ake Gunnar Pilbrant
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of DE69426669D1 publication Critical patent/DE69426669D1/de
Application granted granted Critical
Publication of DE69426669T2 publication Critical patent/DE69426669T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69426669T 1993-04-30 1994-04-26 Tierarzneimittel, das einen protonenpumpeninhibitor enthält Expired - Fee Related DE69426669T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE19939301489A SE9301489D0 (sv) 1993-04-30 1993-04-30 Veterinary composition
PCT/SE1994/000368 WO1994025070A1 (en) 1993-04-30 1994-04-26 Veterinary composition containing a proton pump inhibitor

Publications (2)

Publication Number Publication Date
DE69426669D1 true DE69426669D1 (de) 2001-03-15
DE69426669T2 DE69426669T2 (de) 2001-07-05

Family

ID=20389791

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69426669T Expired - Fee Related DE69426669T2 (de) 1993-04-30 1994-04-26 Tierarzneimittel, das einen protonenpumpeninhibitor enthält

Country Status (33)

Country Link
US (1) US5731002A (de)
EP (1) EP0696921B1 (de)
JP (1) JP3872509B2 (de)
KR (1) KR100324451B1 (de)
CN (1) CN1100570C (de)
AT (1) ATE199060T1 (de)
AU (1) AU678830B2 (de)
BR (1) BR9406363A (de)
CZ (1) CZ285191B6 (de)
DE (1) DE69426669T2 (de)
DK (1) DK0696921T3 (de)
EE (1) EE03137B1 (de)
EG (1) EG20401A (de)
ES (1) ES2155473T3 (de)
FI (1) FI955124A0 (de)
GR (1) GR3035831T3 (de)
HR (1) HRP940267A2 (de)
HU (1) HUT74868A (de)
IL (1) IL109245A (de)
IS (1) IS1694B (de)
LT (1) LT3263B (de)
MA (1) MA23170A1 (de)
NO (1) NO312435B1 (de)
NZ (1) NZ265728A (de)
PL (1) PL176755B1 (de)
PT (1) PT696921E (de)
RU (1) RU2131267C1 (de)
SE (1) SE9301489D0 (de)
SG (1) SG52540A1 (de)
SK (1) SK280465B6 (de)
TN (1) TNSN94035A1 (de)
WO (1) WO1994025070A1 (de)
YU (1) YU22794A (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5708017A (en) * 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
ES2194515T3 (es) * 1998-10-06 2003-11-16 Mars Uk Ltd Estereotipia en animales.
ES2216870T3 (es) * 1999-02-23 2004-11-01 MERCK & CO., INC. Composicion farmaceutica que contiene inhibidores de la bomba de protones.
US6780880B1 (en) * 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
AU2001296908A1 (en) * 2000-09-29 2002-04-08 Geneva Pharmaceuticals, Inc. Proton pump inhibitor formulation
KR20030059318A (ko) 2000-12-07 2003-07-07 알타나 파마 아게 산 불안정성 활성 성분을 포함하는 현탁액 형태의 약학 제제
DE10061135C1 (de) * 2000-12-07 2002-11-07 Byk Gulden Lomberg Chem Fab Pharmazeutische Zubereitung in Form einer Paste enthaltend einen säurelabilen Wirkstoff
SI1341524T1 (sl) * 2000-12-07 2012-02-29 Nycomed Gmbh Farmacevtski pripravek v obliki paste, ki obsega kislinsko labilno učinkovino
US20020192299A1 (en) * 2000-12-28 2002-12-19 Rajneesh Taneja Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
US20040006111A1 (en) * 2002-01-25 2004-01-08 Kenneth Widder Transmucosal delivery of proton pump inhibitors
CO5400144A1 (es) * 2002-03-11 2004-05-31 Novartis Ag Compuestos organicos
US20030228363A1 (en) * 2002-06-07 2003-12-11 Patel Mahendra R. Stabilized pharmaceutical compositons containing benzimidazole compounds
US20040082618A1 (en) * 2002-07-03 2004-04-29 Rajneesh Taneja Liquid dosage forms of acid labile drugs
US20040081671A1 (en) * 2002-07-03 2004-04-29 Rajneesh Taneja Liquid dosage forms of non-enterically coated acid-labile drugs
US20040006109A1 (en) * 2002-07-03 2004-01-08 Rajneesh Taneja Liquid dosage forms of non-enterically coated acid-labile drugs
JP5148813B2 (ja) * 2002-07-03 2013-02-20 タケダ ファーマシューティカルズ ユー．エス．エー． インコーポレイティド プロトンポンプ阻害剤の液体剤形
US20040005362A1 (en) * 2002-07-03 2004-01-08 Rajneesh Taneja Liquid dosage forms of acid labile drugs
US20040121004A1 (en) * 2002-12-20 2004-06-24 Rajneesh Taneja Dosage forms containing a PPI, NSAID, and buffer
US20070243251A1 (en) * 2002-12-20 2007-10-18 Rajneesh Taneja Dosage Forms Containing A PPI, NSAID, and Buffer
US20040248942A1 (en) * 2003-02-20 2004-12-09 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
US20070053981A1 (en) * 2003-07-11 2007-03-08 Eva Blychert Solid composition comprising a proton pump inhibitor
WO2005007115A2 (en) * 2003-07-18 2005-01-27 Santarus, Inc. Pharmaceutical composition for inhibiting acid secretion
US20050031700A1 (en) * 2003-07-18 2005-02-10 Sanatarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
TWI372066B (en) * 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
EP1718303A4 (de) * 2004-02-10 2010-09-01 Santarus Inc Kombination eines protonenpumpenhemmers, puffermittels und einem nichtsteroidalen entzündungshemmenden mittel
GB0403165D0 (en) * 2004-02-12 2004-03-17 Ct Novel uses for proton pump inhibitors
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20060134210A1 (en) * 2004-12-22 2006-06-22 Astrazeneca Ab Solid dosage form comprising proton pump inhibitor and suspension made thereof
JP2006176461A (ja) * 2004-12-24 2006-07-06 Dai Ichi Seiyaku Co Ltd 粒状物
EP1698233A1 (de) * 2005-03-01 2006-09-06 Bayer HealthCare AG Verringerung der Aufnahmefähigkeit von Phosphor in der Tierernährung
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
EP2012756A4 (de) * 2006-04-20 2013-01-23 Inventia Healthcare Private Ltd Zusammensetzungen mit mehreren einheiten
CH698658B1 (de) * 2006-04-24 2009-09-30 Mepha Ag Orale pharmazeutische Formulierung mit schneller Freisetzung für Pyridylmethylsulfinyl-Benzimidazole.
US20100297226A1 (en) * 2006-06-01 2010-11-25 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
CA2658804A1 (en) 2006-07-25 2008-01-31 Vecta Ltd. Compositions and methods for inhibiting gastric acid secretion using derivatives of small dicarboxylic acids in combination with ppi
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
EP2219643B1 (de) * 2007-11-15 2012-05-16 Novartis AG Anthelmintische paste mit praziquantel, einem makrolid-lacton, cyclodextrin und einem verdickungsmittel
US20090227633A1 (en) * 2008-03-04 2009-09-10 Bassam Damaj Methods to inhibit tumor cell growth by using proton pump inhibitors
WO2013058996A1 (en) * 2011-10-19 2013-04-25 R.P. Scherer Technologies, Llc Two phase pharmaceutical delivery system
EP3288556A4 (de) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Oral zerfallende zusammensetzungen
WO2017185123A1 (en) * 2016-04-29 2017-11-02 Alan Thompson Veterinary composition
CN107468652A (zh) * 2016-06-07 2017-12-15 北京新领先医药科技发展有限公司 一种固体干混悬温敏凝胶剂及其制备方法
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CA3033065A1 (en) * 2016-08-11 2018-02-15 Adamis Pharmaceuticals Corporation Drug compositions
EP3720844A4 (de) 2017-12-08 2021-08-11 Adamis Pharmaceuticals Corporation Arzneimittelzusammensetzungen

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL22368A (en) * 1963-11-19 1969-01-29 Merck & Co Inc 2,5(or 6)-bis-heteroaryl substituted benzazoles
BE792990A (fr) * 1971-12-23 1973-06-19 Shell Int Research Procede de lutte contre les endoparasites chez les chevaux
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
AU4640985A (en) 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US5215974A (en) * 1986-11-21 1993-06-01 Aktiebolaget Hassle Certain pyridyl[(methylthio- or methyl sulfinyl)-2 benzimidazol-2-yl]N-methyl phosphonates useful for treating gastric-acid secretion related diseases
US5026560A (en) 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
DK130287D0 (da) * 1987-03-13 1987-03-13 Benzon As Alfred Oralt praeparat
YU48263B (sh) 1991-06-17 1997-09-30 Byk Gulden Lomberg Chemische Fabrik Gmbh. Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
JP5556818B2 (ja) 2009-09-18 2014-07-23 旭硝子株式会社 二次電池用非水電解液

Also Published As

Publication number Publication date
SE9301489D0 (sv) 1993-04-30
JP3872509B2 (ja) 2007-01-24
IS4146A (is) 1994-10-31
MA23170A1 (fr) 1994-12-31
AU6693894A (en) 1994-11-21
PL176755B1 (pl) 1999-07-30
HUT74868A (en) 1997-02-28
KR100324451B1 (ko) 2002-11-01
CZ285191B6 (cs) 1999-06-16
GR3035831T3 (en) 2001-08-31
CZ282595A3 (en) 1996-04-17
IL109245A0 (en) 1994-11-28
EG20401A (en) 1999-02-28
WO1994025070A1 (en) 1994-11-10
LTIP1920A (en) 1994-11-25
NO312435B1 (no) 2002-05-13
EE03137B1 (et) 1998-12-15
JPH08509493A (ja) 1996-10-08
PL311276A1 (en) 1996-02-05
TNSN94035A1 (fr) 1995-04-25
HRP940267A2 (en) 1996-10-31
LT3263B (en) 1995-05-25
BR9406363A (pt) 1996-02-27
AU678830B2 (en) 1997-06-12
YU22794A (sh) 1998-05-15
HU9503085D0 (en) 1995-12-28
US5731002A (en) 1998-03-24
IL109245A (en) 2000-07-16
FI955124A (fi) 1995-10-27
NO954240L (no) 1995-10-23
IS1694B (is) 1998-04-20
NZ265728A (en) 1996-12-20
EP0696921A1 (de) 1996-02-21
DK0696921T3 (da) 2001-03-19
PT696921E (pt) 2001-06-29
CN1100570C (zh) 2003-02-05
ATE199060T1 (de) 2001-02-15
NO954240D0 (no) 1995-10-23
SG52540A1 (en) 1998-09-28
EP0696921B1 (de) 2001-02-07
DE69426669T2 (de) 2001-07-05
FI955124A0 (fi) 1995-10-27
SK135495A3 (en) 1997-03-05
SK280465B6 (sk) 2000-02-14
ES2155473T3 (es) 2001-05-16
RU2131267C1 (ru) 1999-06-10
CN1122109A (zh) 1996-05-08

Similar Documents

Publication Publication Date Title
DE69426669D1 (de) Tierarzneimittel, das einen protonenpumpeninhibitor enthält
BR9604803A (pt) Composição farmacêutica para administração oral
MX9605940A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
ATE275396T1 (de) Aus mehreren einzeleinheiten zusammengesetztes pharmazeutisches präparat, das einen protonenpumpeninhibitor enthält
GB2303629B (en) Hydroxamic acids and their use as metalloproteinase inhibitors
MX9603520A (es) Derivados del acido hidroxamico y acido carboxilico, procesos para su preparacion y su uso.
SE9401406L (sv) Farmaceutiska produkter för att bota tumörsjukdomar samt förfarande för framställning av desamma
IS3284A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
MX9708800A (es) Compuestos biciclicos aromaticos.
FR2755965B1 (fr) Composes biaromatiques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
NO995838L (no) Nye heteroetynylenforbindelser og farmasoeytiske og kosmetiske preparater inneholdende de samme
CA2161683A1 (en) Veterinary composition containing a proton pump inhibitor
DK0927031T3 (da) Farmaceutisk sammensætning indeholdende nimesulid til oral admnistration
TH17624A (th) สูตรผสมทางสัตวแพทย์
MX9605916A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en para, composiciones farmaceuticos y cosmeticas que los contienen y utilizaciones.
RU97109989A (ru) Способ лечения вагинозов и вагинитов у беременных
UA19287A (uk) Діетиламіhоетиламіда 1-пропіл-2-оксо-4-гідроксіхіhолін-3-карбонової кислоти гідрохлорид, що проявляє анестезуючу, протиаритмічhу, аhтиоксидаhтhу, аhтимікробну та фуhгіцидhу активhість
JO1821B1 (en) New pharmaceutical product

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee